Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Breast Surgery
  •  Otolaryngology - Head and Neck Surgery
  •  Emergency Surgery
  •  Vascular Surgery
  •  Pediatric Surgery
  •  Obstetrics Surgery
  •  Cardiovascular Surgery
  •  Transplant Surgery

Abstract

Citation: Clin Surg. 2018;3(1):2071.Research Article | Open Access

Leg Ulcer Treatment using an Innovative Biodegradable Dressing not Requiring Replacements

Ewa Bieniek, Karolina Skołucka-Szary, Andrzej Lewiński and Sylwester Piaskowski

Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute,Poland
Celther Polska Sp. z o.o. Inwestycyjna 7, Poland
Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Poland

*Correspondance to: Ewa Bieniek 

 PDF  Full Text DOI: 10.25107/2474-1647.2071

Abstract

The aim of this study was to evaluate the efficacy of the DibuCell Active dressing, the fully biodegradable dressing based on dibutyrylchitin, in the treatment of venous ulcers. The dressing undergoes full degradation within the wound. It does not require to be replaced (what significantly reduces the traumatization of newly formed tissues) and the only thing that is needed is to add yet another layer of the dressing once the previous one has been degraded. Evaluation of the effectiveness of the dressing was performed based on the analysis of results obtained during the prospective, multicentre, randomized, single-blinded clinical trial ULCERUS 1/2014. Statistical analysis was performed using data obtained from 137 patients. The control group was treated with the Biatain Ag dressing, while the study group with both the DibuCell Active and Biatain Ag dressings. In the control group, 38.24% of ulcers were healed, while in the study group ‒ 34.78%. Comparing only the subset of normotensive patients, the study showed statistically significant differences (p<0.05) in the rate of ulcer healing process between these two groups. The rate of the healing process of ulcers was higher in the group of patients treated with the DibuCell Active and Biatain Ag dressings compared to patients treated only with the Biatain Ag dressing. Adding the investigated dressing to standard therapy results in beneficial acceleration of the healing process. Addition of the DibuCell Active dressing to standard therapy seems to improve the treatment efficacy, especially in the case of large and extensive ulcers.

Keywords

Biodegradable dressings; Chitin dibutyrate; Chronic venous insufficiency; Venous ulcers

Cite the article

Bieniek E, Sko?ucka-Szary K, Lewi?ski A, Piaskowski S. Leg Ulcer Treatment using an Innovative Biodegradable Dressing not Requiring Replacements. Clin Surg. 2018; 3: 2071.

Search Our Journal

Journal Indexed In

Articles in PubMed

Sildenafil Transiently Delays Early Alveolar Bone Healing of Tooth Extraction Sockets
 PubMed  PMC  PDF  Full Text
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Optimal Surgical Procedure for Ovarian Metastases from Colorectal Cancer based on a Retrospective Analysis
 Abstract  PDF  Full Text
The Diagnostic Value of sCD14-ST (Presepsin) in Acute Appendicitis
 Abstract  PDF  Full Text
View More...